Target intelligence / Profile preview

Free extracellular calcium ion (Ca²⁺ (free))

Target
Ca²⁺ (free)
Molecular classification
Other
01

Overview

Free extracellular calcium ion (Ca²⁺) refers to the physiologically active fraction of calcium present in the extracellular fluid, not bound to plasma proteins. Its concentration is tightly maintained (~1.2–1.3 mM in mammals) and is essential for various biological processes, including stabilizing cell membranes, participating in neurotransmitter release, blood coagulation, muscle contraction, and hormone secretion[1][10]. Extracellular Ca²⁺ is not itself a ‘target’ in the pharmacological or molecular sense (it is not a receptor, channel, enzyme, or transporter), but it acts as a critical signal and cofactor in numerous pathways. The main proteins “targeted” therapeutically for calcium homeostasis are the calcium-sensing receptor, vitamin D receptor, and various channels and transporters regulating calcium influx and efflux[3][8][1]. Fluctuations in free extracellular calcium are directly involved in several diseases, notably disorders of bone, kidney, and neural excitability. Drugs that affect calcium levels do so by modifying absorption, excretion, release from bone, or by binding free Ca²⁺; they do not bind Ca²⁺ itself as a structured drug target[1][3][8][10].

Other names
Free Ca²⁺Ionized calciumExtracellular Ca²⁺Free extracellular calcium
02

Mechanism of action

Modulation of extracellular calcium levels alters the activation of calcium-sensing receptors, voltage-gated calcium channels, and various downstream pathways

03

Biological functions

Signal transduction (indirect, via effects on channels/receptors)Maintenance of membrane potentialBone and teeth mineralizationBlood coagulationMuscle contractionNeurotransmitter releaseEnzyme cofactor
04

Disease associations

Cardiovascular diseaseNeuromuscular disordersBone disease (e.g., osteoporosis)Hypocalcemia or hypercalcemia syndromesOther
05

Safety considerations

Hypocalcemia: risk of cardiac arrhythmia, tetany, seizuresHypercalcemia: risk of renal impairment, neurological symptoms, cardiac arrhythmiaRapid changes in extracellular calcium can be life-threatening
06

Interacting drugs

Chelating agents (e.g., EDTA, citrate)

4 more in the full profile.

07

Biomarkers

Serum calcium (free/ionized and total calcium)

Beyond the preview

Go deeper on Free extracellular calcium ion (Ca²⁺ (free)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Free extracellular calcium ion (Ca²⁺ (free)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call